Peter Ordentlich

(Dr. Peter Ordentlich Ph.D.)

Currently holds a position at Syndax Pharmaceuticals Inc

Positions
Position Company Period
Chief Scientific Officer Syndax Pharmaceuticals Inc Sept. 1, 2016 -
Chief Technology Officer Syndax Pharmaceuticals Inc Nov. 1, 2013 - Sept. 1, 2016
Vice President of Translational Medicine, Founder Syndax Pharmaceuticals Inc Jan. 1, 2012 - Oct. 1, 2013
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Total value Details
2023-02-17 2023-02-15
PS Planned sale
17,428 -100.0%
25.84
450,404 USD 		17,428 -100.0% 25.84 450,404 USD
2023-02-17 2023-02-15
PS Planned sale
7,572 -100.0%
25.84
195,688 USD 		7,572 -100.0% 25.84 195,688 USD
2023-02-03 2023-02-01
S Sale
69 -100.0%
28.43
1,962 USD 		69 -100.0% 28.43 1,962 USD
2022-12-02 2022-12-02
PS Planned sale
17,200 -98.5%
25.05
430,936 USD 		17,200 -98.5% 25.05 430,936 USD
2022-12-02 2022-12-01
PS Planned sale
4,028 -93.8%
25.01
100,746 USD 		4,028 -93.8% 25.01 100,746 USD
2022-12-02 2022-12-01
PS Planned sale
3,772 -93.4%
25.01
94,343 USD 		3,772 -93.4% 25.01 94,343 USD
2022-08-26 2022-08-24
PS Planned sale
2,154 -89.0%
25.04
53,927 USD 		2,154 -89.0% 25.04 53,927 USD
2022-08-26 2022-08-24
PS Planned sale
22,846 -98.9%
25.04
571,966 USD 		22,846 -98.9% 25.04 571,966 USD
2022-02-03 2022-02-01
S Sale
1,412 -100.0%
16.65
23,510 USD 		1,412 -100.0% 16.65 23,510 USD
2020-11-25 2020-11-23
S Sale
16,334 -100.0%
22.89
373,924 USD 		16,334 -100.0% 22.89 373,924 USD
2020-11-25 2020-11-23
S Sale
7,954 -32.7%
23.58
187,594 USD 		7,954 -32.7% 23.58 187,594 USD
2020-11-25 2020-11-23
S Sale
5,684 -19.0%
23.33
132,603 USD 		5,684 -19.0% 23.33 132,603 USD